Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Mortality due to COVID-19 infection: A comparison of first and second waves
Olubunmi Oladunjoye1, Molly Gallagher2, Tom Wasser3
1Department of Internal Medicine, Reading Hospital, Tower Health System, Reading, PA, USA.
Insights
COVID-19 mortality was lower in the second wave compared to the first. Increased use of steroids, remdesivir, and convalescent plasma in the second wave may have contributed to improved outcomes.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- The United States experienced two major waves of COVID-19 in 2020.
- The first wave occurred from March to July, followed by a surge in August after business restrictions were eased.
Purpose of the Study:
- To compare demographic characteristics, treatments administered, and mortality rates between the first and second waves of the COVID-19 pandemic.
- To identify factors influencing outcomes during different pandemic phases.
Main Methods:
- A retrospective analysis of 4434 hospitalized COVID-19 patients across a six-hospital health system in the US.
- Data collected between March 1, 2020, and January 31, 2021, were compared between the first and second waves.
Main Results:
- Mortality was significantly higher in the first wave (23.2%) versus the second wave (12.3%).
- The first wave saw a higher proportion of Non-Hispanic Black and Hispanic patients.
- Higher mortality in the first wave persisted after adjusting for multiple clinical and demographic factors.
Conclusions:
- The second wave of COVID-19 had lower mortality than the first wave.
- Increased utilization of steroids, remdesivir, and convalescent plasma was observed in the second wave, correlating with improved survival.
Background:
The USA suffered an initial wave of COVID-19 cases from March to July in 2020. Cases again surged in August 2020 as business restrictions were lifted. We aimed to describe demographic, treatment, and mortality differences between both waves.
Methods:
We identified all hospitalized patients with COVID-19 infection in one US six-hospital health system between 1 March 2020 and 31 January 2021. We compared data obtained on patient demographics, treatment received, and mortality between first and second waves of the pandemic.
Results:
A total of 4434 hospitalized COVID patients were identified, including 1313 patients in the first wave and 3121 patients in the second wave. Mortality was significantly higher in the first wave as compared to the second wave (23.2% vs. 12.3%, p < 0.001). Age and sex were similar in each wave. In the first wave, there were significantly more Non-Hispanic Black patients (28.8 vs. 18.1%, p < 0.001) and Hispanic patients (26.6% vs. 14.9%, p < 0.001) as compared to the second wave. There was a higher mortality rate in the first wave as compared to the second, which persisted after multivariable adjustment for sex, age, ethnicity, laboratory results at admission, treatment received, high flow use and mechanical ventilation (OR: 2.66, 95% CI: 1.83-3.87, p < 0.001).
Conclusion:
Mortality in the second wave was lower than the first wave with significantly higher utilization of steroids, remdesivir and convalescent plasma in second wave.
More Related Videos
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups
Life Tables
Cancer Survival Analysis
Stages of Infection
Assumptions of Survival Analysis

